Glenmark and Cosmo get European approval for Winlevi acne treatment across 15 countries

Glenmark Pharmaceuticals Ltd and Ireland's Cosmo Pharmaceuticals N.V. on Tuesday announced that the European Commission (EC) has granted marketing authorisation for Winlevi (clascoterone 10 mg/g cream) used in treatment of acne vulgaris in 15 countries in Europe. The marketing authorisation by EC follows the positive opinion issued by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) on August 25, 2025, Glenmark Pharmaceuticals Ltd said in a regulatory filing. "The appro ...